Home » Blog » Recall of sterile compounded products impacts Illinois residents

Recall of sterile compounded products impacts Illinois residents

A Massachusetts-based pharmacy is recalling all of its products manufactured in 2013.

Pallimed Solutions, Inc., doing business as Pallimed Pharmacy, announced the recall after state inspectors found particles floating in vials of the pharmacy’s compounded products. Federal health officials warn that the particulates (filaments) can lead to blood vessel damage, induce emboli, and cause other negative reactions such as allergic attacks or serious tissue responses.

The pharmacy’s products come in glass vials have many uses including treating erectile dysfunction, vitamin injections and ophthalmic preparations. The products were distributed nationwide, including in Illinois.

“At this time a total of 5 affected vials were discovered,” the FDA said in its recall notice. “To date, no injuries or illnesses have been reported. In an abundance of caution, the pharmacy included all sterile compounded products dispensed since January 1, 2013, in the voluntary recall.”

The recall follows a deadly fungal meningitis outbreak caused by poor safety standards at another compounding pharmacy. That outbreak, which occurred last fall, left 51 people dead, sickened hundreds, and launched a wave of product liability lawsuits.

Source: FDA, “Pallimed Solutions, Inc. Announces Voluntary Nationwide Recall of All Sterile Compounded Products Dispensed Since January 1, 2013 Due to Possible Filament Contamination,” Mar. 25, 2013